What is the mechanism of action of carbidopa

The mechanism of action of carbidopa is to promote the release of dopamine in the human body. Generally, it needs to be combined with levodopa to enhance its efficacy, smoothly penetrate the human blood-brain barrier, and allow the drug to enter the brain and take effect.
Kabidopa is a drug used to treat Parkinson's disease. It can promote the release of endogenous dopamine and also has anticholinergic properties. Due to its hydrazine group, monotherapy can only inhibit the decarboxylation of peripheral levodopa, making it difficult to penetrate the blood-brain barrier. In clinical practice, it is often used in combination with levodopa, which can inhibit the conversion of peripheral levodopa to dopamine, increase the content of levodopa in the circulation, and increase the amount entering the central nervous system. When used in combination with levodopa, it can reduce the adverse effects of levodopa on the peripheral cardiovascular system and is used for Parkinson's disease caused by various reasons. At this point, carbidopa will enter the brain and have a significant effect on treating Parkinson's disease and Parkinson's syndrome.
When using carbidopa in combination with levodopa, gradually increase the dosage according to medical advice. It is recommended to take 10mg of carbidopa once, 3-4 times a day. Gradually increase the daily dose every 1-2 days, with a maximum daily dose of 100mg. It is recommended to start taking 0.25g of levodopa once, 2-4 times a day, after meals. In the future, based on the patient's tolerance, the dosage will be increased every 3-7 days, with a specific range of 0.125-0.75g per day, until the desired therapeutic effect is achieved. Levodopa should be taken in a maximum amount of 6g per day, divided into 4-6 doses.
Parkinson's disease is a neurological disorder in which patients exhibit abnormal walking postures, such as hand tremors, leg tremors, and slow movements. In clinical practice, there is no specific drug for this disease, and only combination therapy can be used according to the condition. The combination of carbidopa and levodopa can inhibit abnormal brain discharge in patients and have a certain effect on controlling early disease. But as the disease progresses, patients develop drug resistance, which can lead to a decrease in drug efficacy. Treatment can be achieved through minimally invasive cell knife surgery, and patients can choose the appropriate treatment plan according to their own condition.
In addition, appropriate exercise is needed in daily life to prevent limb contractures and joint stiffness, allowing patients to retain a certain level of mobility. In addition, it is important to maintain a balanced diet by consuming high protein and fiber rich foods, as well as fresh vegetables and fruits.